The reno-protective effects of atorvastatin in crush syndrome and rhabdomyolysis:is there a dilemma?
Yıldız, Can Gökay
Özdamar, Emine Nur
MetadataShow full item record
CitationAcar, D., Gülpembe, M., Yıldız, C. G., Özdamar, E. N., Açıkgöz, K., Çağlar, A., Cander, B. (2017). The reno-protective effects of atorvastatin in crush syndrome and rhabdomyolysis:is there a dilemma?. Turkish Journal of Medical Sciences, 47, 6, 1920-1924.
Background/aim: We aim to determine the effects of low-dose atorvastatin treatment together with crush fluid resuscitation on renal functions and muscle enzyme levels in a rat model of crush syndrome. Materials and methods: The study involved female Wistar Albino rats weighing 250300 g that were housed with free access to food and water. The crush model was obtained by compression. Rats were randomly divided into four groups: control (C) group, atorvastatin crush fluid (ACF) group, crush fluid (CF) group, and hypertonic saline (%3) mannitol sodium bicarbonate (SM) group. Blood was obtained at 24, 48, and 72 h, and serum creatinine kinase, myoglobin, urea, creatinine, and lactate dehydrogenase levels were studied. Results: All parameters were statistically significantly higher in the control group than in the treatment groups at all hours. However, there was no statistically significant difference among treatment groups regarding any of the parameters. Conclusion: This is the first study determining the role of atorvastatin in the treatment of renal ischemia/reperfusion injury in a crush syndrome and rhabdomyolysis model setting. Larger studies with different atorvastatin doses are required to define the role of this drug in the treatment of renal ischemia/reperfusion injury during crush syndrome.
SourceTurkish Journal of Medical Sciences